The law offices of O'Connor, Acciani & Levy are currently investigating potential Invokana lawsuits on behalf of individuals who suffered ketoacidosis or kidney failure after taking the diabetes drug Invokana. If you or someone you know has been hospitalized with injuries after taking Invokana or similar drugs, it is in your best interest to talk with an experienced defective drug attorney. You may be entitled to financial compensation through an Invokana lawsuit. The Cincinnati Invokana lawyers at O'Connor, Acciani & Levy offer a free consultation and charge no upfront costs or legal fees unless you recover compensation.
INVOKANA SIDE EFFECTS
Diabetes patients are already struggling with one illness, they do not deserve to be harmed by the very medications that are supposed to protect them. Invokana and similar type 2 diabetes drugs have been linked to numerous medical conditions ranging from mild to very serious. Among the more serious side effects of Invokana are conditions that involve:- Diabetic ketoacidosis
- Myocardial infarction
- Kidney failure
DIABETIC KETOACIDOSIS
Diabetic ketoacidosis is a dangerous condition associated with drugs like Invokana. Patients taking Invokana may find that their body cannot access the body's stores of sugar and instead begins to rely on fat stores for energy, leading to diabetic ketoacidosis. The ketones produced by diabetic ketoacidosis raise the levels of acids in the blood and if left untreated, the condition can be fatal. Symptoms of ketoacidosis include:- Increased thirst
- Loss of appetite
- Confusion
- Rapid breathing
- Difficulty getting up in the morning
- Kidney failure
- Heart attack
MYOCARDIAL INFARCTION
Invokana is being linked to myocardial infarction. The condition occurs when the heart does not receive a sufficient supply of blood and the cells of the heart are damaged or die.- In clinical trial data reviewed by physicians, Johnson & Johnson revealed that 13 patients suffered a heart attack or stroke within thirty days of beginning a regimen of Invokana.
- In clinical trials, the risk of heart attack or other cardiovascular injury to patients taking Invokana was 600 percent greater than the risk to patients who were prescribed a placebo.
KIDNEY DAMAGE
In 2014, Johnson & Johnson announced that it would begin testing Invokana to treat diabetic kidney disease (nephropathy). Many diabetes patients experience chronic kidney disease, and the company is seeking to position Invokana as an alternative treatment for kidney disease. Among the members of the FDA committee who reviewed the safety of Invokana, one third (5 out of 15) urged the FDA to reject the drug and prevent its sale in America. Among other things, researchers were concerned that the drug did not offer a patients any benefits that were not available on the market and that the trials indicated severe side effects.FDA ISSUES A SAFETY ALERT
The U.S. Food and Drug Administration (FDA) received numerous reports that diabetes patients being treated with Invokana were being hospitalized after complications. In response to the reports, the FDA issued a safety communication warning in May 2015 to warn patients and doctors about the dangers posed by type 2 diabetes drugs such as Invokana. Other diabetes medications in the same class as Invokana include:- Invokamet
- Farxiga
- Xigduo XR
- Jardiance
- Glyxambi